Delivery Order SPE2DB20D3101-SPE2DB25FRVS6
- Not listed
- The Defense Logistics Agency awarded a $7,772.26 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Gemtesa 75 mg tablets (30-count units). The contract represents a firm fixed price, non-set-aside award with an ultimate completion date of September 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) at a ceiling value of $2,378.33. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 29, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,938.51 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Gemtesa 75 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 12, 2025. The award will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $12,076.72 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). The contract, which is non-set-aside and competitively awarded, designates Conshohocken, Pennsylvania as the place of performance and carries an ultimate completion date of September 16, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) valued at $19,403.29. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,456.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). The contract, which represents a non-competitive delivery order, is scheduled for completion by July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is a child delivery order executed under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $25,001.39 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gemtesa 75 mg tablets in quantities of 90 units. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed price contract valued at $43,743.38. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 17, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as...
- The Defense Logistics Agency awarded a $133,014.83 delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gemtesa 75 mg tablets (30-count packaging) with a contract value of $4,028.92. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and represents a non-competitive set-aside award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVS6Delivery Order
The Defense Logistics Agency awarded a $40,427.97 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal vendor for military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical and medical supply offerings. The SPE2DX prime contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. This specific delivery order for Gemtesa—an overactive bladder treatment—exemplifies the company's role in providing specialized pharmaceutical products across multiple therapeutic domains to meet federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.4k | 9/16/25 |